Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glasdegib in sclerotic chronic graft-versus-host disease
NCT03415867Phase 2Unknown
- Sponsor
- GETH-TC
- Start
- Jan 2018
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glasdegib in chronic graft-versus-host disease (cGVHD), sponsored by GETH-TC. Status: unknown.
02
Drugs
glasdegib
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT03415867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03415867.